Amrutanjan Healthcare, a prominent player in the Indian healthcare industry, is headquartered in Chennai, India. Founded in 1893, the company has established itself as a leader in pain relief and wellness products, with a strong presence across various operational regions in India and beyond. Specialising in over-the-counter healthcare solutions, Amrutanjan is renowned for its unique range of products, including pain balms, nasal inhalers, and herbal remedies. The brand's commitment to quality and innovation has earned it a loyal customer base and significant market recognition. With a legacy spanning over a century, Amrutanjan Healthcare continues to set benchmarks in the industry, focusing on holistic health and well-being, while consistently expanding its product offerings to meet evolving consumer needs.
How does Amrutanjan Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Amrutanjan Healthcare's score of 18 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Amrutanjan Healthcare reported total carbon emissions of approximately 2,195,910 kg CO2e, comprising 1,083,598 kg CO2e from Scope 1 and 1,116,312 kg CO2e from Scope 2. This reflects a slight increase in emissions compared to 2022, when the company recorded about 2,028,575 kg CO2e, with 938,930 kg CO2e from Scope 1 and 1,091,645 kg CO2e from Scope 2. Amrutanjan Healthcare has not disclosed any Scope 3 emissions data, nor have they set specific reduction targets or climate pledges. The company’s emissions intensity for Scope 1 and Scope 2 combined is reported at 0.00000058 kg CO2e per rupee of turnover, and 1,877.02 kg CO2e per unit of physical output. As of now, there are no cascading emissions data from a parent or related organization, and all reported figures are directly from Amrutanjan Health Care Limited. The company continues to monitor its carbon footprint as part of its commitment to sustainability, although specific reduction initiatives or targets have not been outlined.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 938,930 | 0,000,000 |
| Scope 2 | 1,091,645 | 0,000,000 |
| Scope 3 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amrutanjan Healthcare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

